Caribou Biosciences (CRBU) Stock Research

Caribou Biosciences

· CRBU

Dashboard

Financials

Ratios

Valuation

Statistics

132.937 M

+2.42%

Over a week ago

Caribou Biosciences price target lowered by $1 at BofA, here's why

CRBU

Aug 14, 6:59 AM

Caribou Biosciences reports Q2 EPS (24c), consensus (31c)

CRBU

Aug 13, 4:44 PM

Citizens biotech analyst holds an analyst/industry conference call

Jul 6, 2:30 PM

Citizens biotech analysts hold an analyst/industry conference call

Jul 2, 3:21 PM

Caribou Biosciences presents ANTLER trial results at EHA

CRBU

Jun 11, 8:55 AM

FDA Commissioner Marty Makary resigns

+17

May 12, 1:58 PM

Caribou Biosciences price target raised by $2 at H.C. Wainwright, here's why

CRBU

May 11, 6:17 AM

Caribou CB-011 granted Regenerative Medicine Advanced Therapy designation

CRBU

Mar 31, 8:06 AM

Caribou Biosciences price target raised by $2 at Evercore ISI, here's why

CRBU

Mar 9, 8:05 AM

Caribou Biosciences reports Q4 EPS (28c) vs. (39c) last year

CRBU

Mar 5, 4:23 PM

Caribou Biosciences initiated with bullish view at Clear Street, here's why

CRBU

Feb 2, 4:22 PM

Caribou Biosciences price target lowered by $2 at BofA, here's why

CRBU

Jan 6, 10:14 AM

Caribou Biosciences reports Q3 EPS (30c) vs. (38c) last year

CRBU

Nov 12, 5:24 PM

FDA appoints Richard Pazdur as Director of CDER

+16

Nov 11, 4:27 PM

Caribou Biosciences price target raised by $6 at H.C. Wainwright, here's why

CRBU

Nov 5, 6:17 AM

Caribou Biosciences price target raised by $3 at Citi, here's why

CRBU

Nov 3, 10:13 AM

Caribou Biosciences announces results from CaMMouflage Phase 1 trial

CRBU

Nov 3, 7:15 AM

Caribou Biosciences announces results from ANTLER phase 1 trial of vispa-cel

CRBU

Nov 3, 7:14 AM

Video: This stock is dragging down the in vivo gene editing therapy space

Oct 27, 1:53 PM

Intellia Therapeutics price target lowered by $6 at BofA, here's why

Oct 27, 11:27 AM

No more stories

Charts